Suit Says Abbott Conspired To Block Generic TriCor

Law360, New York (March 18, 2008, 12:00 AM EDT) -- Eighteen states and the District of Columbia have filed a lawsuit alleging that Abbott Laboratories and Fournier Industrie et Sante conspired to delay and prevent a generic version of their TriCor cholesterol drug from reaching the market by filing a series of frivolous patent infringement lawsuits.

The suit, which was filed Tuesday in the U.S. District Court for the District of Delaware, says that Abbott and its French partner brought a series of groundless patent lawsuits against generics companies, citing patents the two companies had obtained...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.